Aarey Drugs & Pharmaceuticals Other Announcement
Aarey Drugs & Pharmaceuticals Ltd filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulations.
ALFA Filings
Every announcement, straight from the exchange
Every Aarey Drugs & Pharmaceuticals other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Aarey Drugs & Pharmaceuticals Ltd filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulations.
Aarey Drugs & Pharmaceuticals Ltd filed its quarterly shareholding pattern. This is a routine regulatory compliance disclosure regarding the company's equity distribution.
The company has filed its quarterly shareholding pattern for the period ending June 30, 2026, as per regulatory requirements.
Aarey Drugs & Pharmaceuticals filed its Annual Secretarial Compliance Report for FY 2025-26. The report details regulatory compliance status and observations from the practicing company secretary.